Polypeptides, derived from endonexin 2, having hepatitis b...

Details Polypeptides, derived from endonexin 2, having hepatitis b... Polypeptides, derived from endonexin 2, having hepatitis b...

C - Chemistry, Metallurgy

12

Q

C12Q 1/68 (2006.01) A01K 67/027 (2006.01) A61K 38/10 (2006.01) A61K 38/16 (2006.01) A61K 38/17 (2006.01) A61K 39/29 (2006.01) A61K 39/395 (2006.01) C07K 14/47 (2006.01) C07K 14/705 (2006.01) C07K 16/00 (2006.01) C07K 16/18 (2006.01) C07K 16/42 (2006.01) C12N 15/85 (2006.01) C12Q 1/02 (2006.01) G01N 33/566 (2006.01) G01N 33/576 (2006.01) G01N 33/577 (2006.01) A61K 38/00 (2006.01) A61K 39/00 (2006.01)

Patent

CA 2139735

The invention relates to a pharmaceutical composition which can contain as active substance: a polypeptide having the property of being the receptor of large and/or major HBsAg, and containing or constituted by human endonexin II, with said polypeptide being present in an amount from 0.6 to 50 mg/kg bodyweight, preferably from 10 to 15 mg/kg bodyweight. The pharmaceutical compositions of the invention are useful for the treatment and diagnosis of HBV infection.

Affiliated with

Also associated with

Rating

Polypeptides, derived from endonexin 2, having hepatitis b... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polypeptides, derived from endonexin 2, having hepatitis b..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polypeptides, derived from endonexin 2, having hepatitis b... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1770542